AMRX
Price
$8.06
Change
+$0.06 (+0.75%)
Updated
Jul 25 closing price
Capitalization
1.87B
9 days until earnings call
HROW
Price
$36.19
Change
-$1.05 (-2.82%)
Updated
Jul 25 closing price
Capitalization
467.85M
16 days until earnings call
Interact to see
Advertisement

AMRX vs HROW

Header iconAMRX vs HROW Comparison
Open Charts AMRX vs HROWBanner chart's image
Amneal Pharmaceuticals
Price$8.06
Change+$0.06 (+0.75%)
Volume$1.12M
Capitalization1.87B
Harrow
Price$36.19
Change-$1.05 (-2.82%)
Volume$325.48K
Capitalization467.85M
AMRX vs HROW Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. HROW commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and HROW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AMRX: $8.06 vs. HROW: $36.19)
Brand notoriety: AMRX and HROW are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 71% vs. HROW: 77%
Market capitalization -- AMRX: $1.87B vs. HROW: $467.85M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. HROW’s [@Pharmaceuticals: Other] market capitalization is $467.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • HROW’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • HROW’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRX and HROW are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.13% price change this week, while HROW (@Pharmaceuticals: Other) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 05, 2025.

HROW is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than HROW($468M). AMRX has higher P/E ratio than HROW: AMRX (90.00) vs HROW (39.53). HROW YTD gains are higher at: 7.869 vs. AMRX (1.768). AMRX has higher annual earnings (EBITDA): 400M vs. HROW (9.95M). AMRX has more cash in the bank: 91.5M vs. HROW (82.8M). HROW has less debt than AMRX: HROW (191M) vs AMRX (2.75B). AMRX has higher revenues than HROW: AMRX (2.39B) vs HROW (130M).
AMRXHROWAMRX / HROW
Capitalization1.87B468M400%
EBITDA400M9.95M4,018%
Gain YTD1.7687.86922%
P/E Ratio90.0039.53228%
Revenue2.39B130M1,842%
Total Cash91.5M82.8M111%
Total Debt2.75B191M1,440%
FUNDAMENTALS RATINGS
AMRX vs HROW: Fundamental Ratings
AMRX
HROW
OUTLOOK RATING
1..100
6512
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
5946
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
5839
P/E GROWTH RATING
1..100
2711
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (79) in the Pharmaceuticals Other industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is in the same range as AMRX (59) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as AMRX (58) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as AMRX (27) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXHROW
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEEFX82.780.37
+0.45%
T. Rowe Price Tax-Efficient Equity I
CCQYX15.870.06
+0.38%
Columbia Disciplined Core Inst3
MRGSX23.340.03
+0.13%
BlackRock Advantage Global R
SEPCX9.78N/A
N/A
Saratoga Energy & Basic Materials C
RPFRX41.48-0.07
-0.17%
Davis Real Estate A

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.75%
PAHC - AMRX
47%
Loosely correlated
-0.88%
VTRS - AMRX
45%
Loosely correlated
+0.64%
AMPH - AMRX
40%
Loosely correlated
-1.15%
EBS - AMRX
39%
Loosely correlated
-4.02%
ZTS - AMRX
39%
Loosely correlated
-0.46%
More

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-2.81%
AMRX - HROW
46%
Loosely correlated
+0.75%
EBS - HROW
39%
Loosely correlated
-4.02%
OGI - HROW
34%
Loosely correlated
+1.32%
AMPH - HROW
32%
Poorly correlated
-1.15%
VTRS - HROW
31%
Poorly correlated
+0.64%
More